Endo Pharmaceuticals Solutions Overview
- Year Founded
-
1988
- Status
-
Acquired/Merged
- Employees
-
246
- Latest Deal Type
-
M&A
Endo Pharmaceuticals Solutions General Information
Description
Operator of a biotechnology platform designed to develop and commercialize specialty pharmaceutical. The company's biotechnology platform develops and commercializes specialty pharmaceuticals through internal research and development and strategic partnerships is advancing the state-of-art of drug delivery with its innovative Hydron Implant technology, enabling physicians to treat conditions in urology and endocrinology.
Contact Information
Corporate Office
- 100 Endo Boulevard
- Chadds Ford, PA 19317
- United States
Corporate Office
- 100 Endo Boulevard
- Chadds Ford, PA 19317
- United States
Endo Pharmaceuticals Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 02-Jun-2014 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 05-Jan-2009 | Completed | Generating Revenue | |||
| 2. IPO | 08-Mar-1990 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Generating Revenue |
Endo Pharmaceuticals Solutions Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Endo Pharmaceuticals Solutions Patents
Endo Pharmaceuticals Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-150827-S | Tool for inserting an implant beneath the skin of patient | Inactive | 24-Oct-2012 | ||
| CA-150826-S | Tool for creating a space beneath the skin of a patient to receive an implant | Inactive | 24-Oct-2012 | ||
| CA-2739179-A1 | Implantable device for the delivery of histrelin and methods of use thereof | Inactive | 30-Sep-2008 | ||
| EP-2344125-A1 | Implantable device for the delivery of histrelin and methods of use thereof | Inactive | 30-Sep-2008 | ||
| JP-2012504139-A | Implantable device for delivery of histrelin and method of use thereof | Pending | 30-Sep-2008 | A61L31/06 |
Endo Pharmaceuticals Solutions Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endo Pharmaceuticals Solutions Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endo International | Corporation | Majority | ||
| Tech Council Ventures | Venture Capital | Minority |
Endo Pharmaceuticals Solutions FAQs
-
When was Endo Pharmaceuticals Solutions founded?
Endo Pharmaceuticals Solutions was founded in 1988.
-
Where is Endo Pharmaceuticals Solutions headquartered?
Endo Pharmaceuticals Solutions is headquartered in Chadds Ford, PA.
-
What is the size of Endo Pharmaceuticals Solutions?
Endo Pharmaceuticals Solutions has 246 total employees.
-
What industry is Endo Pharmaceuticals Solutions in?
Endo Pharmaceuticals Solutions’s primary industry is Pharmaceuticals.
-
Is Endo Pharmaceuticals Solutions a private or public company?
Endo Pharmaceuticals Solutions is a Private company.
-
What is Endo Pharmaceuticals Solutions’s current revenue?
The current revenue for Endo Pharmaceuticals Solutions is .
-
Who are Endo Pharmaceuticals Solutions’s investors?
Endo International and Tech Council Ventures have invested in Endo Pharmaceuticals Solutions.
-
When was Endo Pharmaceuticals Solutions acquired?
Endo Pharmaceuticals Solutions was acquired on 02-Jun-2014.
-
Who acquired Endo Pharmaceuticals Solutions?
Endo Pharmaceuticals Solutions was acquired by Asana BioSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
